On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...

Migraine pain can be mild or severe, but is often debilitating. Discover how long it lasts and the best migraine pain medications to try for relief.

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Allay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational ...

To manage the daily pain, frequent brain fog, and sporadic days of full-body exhaustion, my primary care doctor suggested a ...